SRC and gastric cancer: For instance, our previous study has showed that LOXL4 promotes gastric cancer progression via activating the FAK/Src pathway [11]; LOXL4 knockdown enhances tumor growth and lung metastasis through collagen-dependent extracellular matrix changes in triple-negative breast cancer [14].